Liver transplantation is a preferable alternative to palliative therapy for selected patients with advanced hepatocellular carcinoma

Aravinthan, Aloysious D.; Bruni, Silvio G.; Doyle, Adam C.; Thein, Hla-Hla; Goldaracena, Nicolas; Issachar, Assaf; Lilly, Leslie B.; Selzner, Nazia; Bhat, Mamatha; Sreeharsha, Boraiah; Selzner, Markus; Ghanekar, Anand; Cattral, Mark S.; McGilvray, Ian D.; Greig, Paul D.; Renner, Eberhard L.; Grant, David R.; Sapisochin, Gonzalo

doi:10.1245/s10434-017-5789-3

All Outputs (3)

Telomere, telomerase and liver disease (2017)
Journal Article
Aravinthan, A. D., & Alexander, G. J. (in press). Telomere, telomerase and liver disease. Liver International, 38(1), https://doi.org/10.1111/liv.13630

Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study (2017)
Journal Article
Aravinthan, A. D., Barbas, A. S., Doyle, A. C., Tazari, M., Sapisochin, G., Cattral, M. S., …Renner, E. L. (in press). Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study. Transplant International, https://doi.org/10.1111/tri.13008

Whether and when recovery beyond the need for transplant may occur in patients listed for decompensation remains unclear. This study aimed to investigate the characteristics of patients delisted following recompensation. Seventy-seven patients who we... Read More about Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.

Liver transplantation is a preferable alternative to palliative therapy for selected patients with advanced hepatocellular carcinoma (2017)
Journal Article
Aravinthan, A. D., Bruni, S. G., Doyle, A. C., Thein, H., Goldaracena, N., Issachar, A., …Sapisochin, G. (2017). Liver transplantation is a preferable alternative to palliative therapy for selected patients with advanced hepatocellular carcinoma. Annals of Surgical Oncology, 24(7), https://doi.org/10.1245/s10434-017-5789-3

Background: Patients with hepatocellular carcinoma (HCC) beyond the traditional criteria (advanced HCC) are typically offered palliation, which is associated with a 3-year survival rate lower than 30%. This study aimed to describe the outcomes for a... Read More about Liver transplantation is a preferable alternative to palliative therapy for selected patients with advanced hepatocellular carcinoma.